Physician profile
Naina Batish
NPI 1063425296
$2,877.66
in general payments reported to CMS, 2019-2025
23 companies · $615 in 2025
The $615 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $302 · 2021: $333 · 2022: $325 · 2023: $563 · 2024: $439 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $540.46 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $366.24 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $267.23 | 2019-2024 | Bexsero, Menveo, Pediarix |
| Corium, LLC | $245.36 | 2021-2024 | Azstarys |
| Sanofi Pasteur INC. | $235.77 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $209.27 | 2020-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Tris Pharma INC | $186.84 | 2023-2025 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $134.04 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $132.68 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $123.07 | 2019-2025 | Doc Band |
| Neos Therapeutics, LP | $62.01 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $59.80 | 2025 | Neffy |
| Sobi, INC | $59.32 | 2019-2020 | |
| Seqirus USA INC | $48.71 | 2025 | Flucelvax |
| Biomarin Pharmaceutical INC. | $36.66 | 2024-2025 | Voxzogo 1.2mg |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $34.34 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $26.98 | 2024 | Koselugo |
| Astrazeneca Pharmaceuticals LP | $25.36 | 2023 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $24.96 | 2025 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $15.78 | 2023 | Airduo Digihaler |
| Adlon Therapeutics L.P. | $14.56 | 2020 | |
| Harmony Biosciences LLC | $14.54 | 2025 | |
| Arbor Pharmaceuticals, INC. | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naina Batish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.